2,2',4,4',5-PENTABROMODIPHENYL ETHER CAS NO.60348-60-9

Min.Order: 1 Gram
Payment Terms: L/C,T/T,MoneyGram,Other

Product Details

Keywords

PBDE-99
BDE99
1,2,4-Tribromo-5-(2,4-dibromophenoxy)benzene

Quick Details

ProName: 2,2',4,4',5-PENTABROMODIPHENYL ETHER
CasNo: 60348-60-9
Molecular Formula: C12H5Br5O
Appearance: Powder
Application: intermediate
DeliveryTime: 7-15 working days
PackAge: Aluminumfoil bag, plastic bottle, card...
Port: Shanghai/ Guangzhou/any other ports in...
ProductionCapacity: 20 Metric Ton/Month
Purity: ≥ 99.0%
Storage: 2-8°C
Transportation: by air/sea/express,according to demand...
LimitNum: 1 Gram

Superiority

Product Description

Chemical Name	2,2',4,4',5-Pentabromodiphenyl Ether (>80%)(Contains ~10% 2,2',4,4',5,5'-Hexabromomdiphenyl Ether)
Synonyms	1,2,4-Tribromo-5-(2,4-dibromophenoxy)benzene; 2,2',4,4',5-Pentabromodiphenyl Oxide; BDE 99; PBDE 99; Tardex 50; Tardex 50L
CAS Number	60348-60-9
Molecular Formula	C12H5Br5O
Appearance	White to Pale Pink Semi-Solid to Solid
Melting Point	86-89°C
Molecular Weight	564.69
Storage	Amber Vial, -20°C Freezer, Under inert atmosphere
Solubility	Chloroform (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly, Heated)
Stability	Light Sensitive
Category	Building Blocks; Pharmaceutical/API Drug Impurities/Metabolites;
Applications	2,2',4,4',5-Pentabromodiphenyl ether is part of a group of polybromatinated diphenyl ethers that are widely used as brominated flame retardants. 2,2',4,4',5-Pentabromodiphenyl ether is suspected to be a toxic substance to humans, causing endocrine mediated effects on the body and possibly causing developmental effects in nursed babies. One of the new POPs under the Stockholm Convention
	Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package

Details

Wuhan BJM Pharm Inc. was found in 2013, located in Hubei Province, where has long history, rich culture, convenient traffic, beautiful environment and preferential policy.

We have two factories in Dezhou , Shandong and Xianning, Hubei. The factory covers an area of 48,000 square meters with the building area of 26,000 square meters. We are specialized in the manufacture of pharmaceutical intermediates and cosmetic additives with good inspection equipments and innovative R & D capability.

In 2006, We established Lingxian Microworld Chemical New Material Co,.Ltd.

In 2008, We passed ISO quality system certificate

In 2013, We established Wuhan Benjamin Pharmaceutical Chemical Co.,Ltd , and obtain self-operation Import & Export right, mainly responsible for domestic and foreign business. At the same time, we set up R&D lab in Wuhan,Hubei province, can undertake various custom synthesis of intermediates and APIs.

In 2016, obtain a registered trademark “ BJM ”.

In 2017, we applied for the invention patent of TRIS, and in 2018, we applied for the invention patent of ERDOSTAN intermediate（DL-HOMO）. At present, we have6 patents passed the preliminary examination, and 4 patents are under examination and approval.

In 2019, we purchased a R&D and office building with a total area of 2500 square meters, as our headquarters in Wuhan.

In 2020, we registered BJM Pharm Yunmeng Co., Ltd, and the new production base settled in Geputan chemical park with a total area of 50000 square meters.

We are specialized in the R&D ,production and sales of Erdosteine ,Pirfenidone, Telmisartan, Letrozole , Sitagliptin phosphate, Dapagliflozin , Tris , IPTG and related intermediates.

We stick to the principle as: people-oriented, customer first, Hope to establish a win-win business relationship with all friends.